Livostin Augentropfen, Augentropfensuspension

7680504960234 CH-50496 Augentropfensuspension
Livostin Augentropfen, Augentropfensuspension
Livostin Augentropfen, Augentropfensuspension
Livostin Augentropfen, Augentropfensuspension
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
ml
Galenic form
Augentropfensuspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/04/2025
Patient information leaflet
Français
28/04/2025
Patient information leaflet
Italien
28/04/2025
Summary of Product Characteristics
Allemand
28/04/2025
Summary of Product Characteristics
Français
28/04/2025
Summary of Product Characteristics
Italien
28/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
9.5 MG Substance HBESI
(N/A)
0.15 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.35
Specialties list
Yes
Generic
No
SL addition date: 15/03/1992

Authorization holder

JNTL Consumer Health II

6343 Risch

Authorization information

Swissmedic authorization number
50496
Drug name
Livostin Augentropfen, Augentropfensuspension
Galenic form
AUGN
ATC Code
S01GX02
Authorization status
Z
Dispensing category
D
First authorization
28/02/1992
Authorization expiration date
31/12/9999
IT Number
11.06.2.
Domain
Human medicine
Field of application
Allergische Konjunktivitis

Package details

Description (FR)
LIVOSTIN gtt opht 0.5 mg/ml fl 4 ml
Description (DE)
LIVOSTIN Gtt Opht 0.5 mg/ml Fl 4 ml
Market launch
28/02/1992
Narcotic (BTM)
No